Research Financial News

James Harris Simons, founder of Renaissance Technologies, was a pioneer of quantitative investing (QI) across asset classes. While he was less famous than some of his peers like Charlie Munger and Warren Buffett, he was equally, if not more, successful in investing, outperforming markets with an amazing level of consistency. The popular statistic floating around is that $1,000 in his signature Medallion Fund — known for its consistent gains and only accessible to Renaissance's owners and employees — in 1988 would be worth $42 mn today, compared to $40,000 if invested in S&P 500 and $1,52,000 in Berkshire Hathaway shares over the same period. Today, Renaissance manages $106 bn in assets. As estimated by Forbes, Simons' net worth equates to $31 bn. Simons was a leading philanthropist who gave away billions during his lifetime to support medical and science research and teaching. His journey had been exciting and intriguing. A maths genius, he was only 23 when he received his PhD from the University of California, Berkeley. Subsequently, aside from teaching at prestigious universities, he worked as a breaker of Soviet codes at the Institute for Defense Analyses, a position he held until he had divergent views on the Vietnam War.

Gold price declines ahead of US inflation data, silver gains marginally The previous session also saw a lift in oil prices to a one-week high, supported by reports of increased crude oil imports in China during April. Furthermore, investors interpreted the cooling U.S.

bones, mental health-related issues and weak limbs? One of the main factors could be due to Vitamin D deficiency. Now, a leading fitness Doctor from the UK has explained the benefits of this important Vitamin in preventing dementia and Colon Cancer. This has been reported by ‘Mirror’ in the UK.

Gold and silver prices today on 13-05-2024: Check latest rates in your city Gold prices are seen trading slightly lower today amid profit-booking and weighed by a stronger U.S. dollar, as focus turns on the U.S.

A recent survey by Achieve, a digital personal finance company, highlights the challenges American households face in managing debt amid rising inflation and stagnant wages.

BENGALURU : Reliance-backed electric vehicle maker Altigreen, unable to raise funds over the past year amid a surgical restructuring, is now chasing a metric that’s become the investors’ darling: profitability. That, however, might be a long and bumpy road. As part of a restructuring in December after the company failed to raise funds last year, Altigreen laid off about 200 employees and cut salaries by 30-40% to pare expenses, two people familiar with its operations told Mint, requesting anonymity.

bias, he says, he would like to eliminate the most if he had a magic wand. But it is built so deeply into the structure of the mind that you couldn’t change it without changing many other things – “Overconfidence” is the most damaging among all, says Daniel Kahneman, the Israeli-American author, psychologist, and economist who is known for his work in behavioural economics for which he was jointly awarded the 2002 Nobel Memorial Prize in Economic Sciences. I have been so fascinated by Kahneman’s writings and the way he explains the complexities of the human mind in decision making, that I decided to write about this Nobel Prize laureate’s tragic demise recently, which has left a void in the field of financial decision making.

GriffinAI, launched in Switzerland by crypto veteran Oliver Feldmeier, aims to enhance AI Agents capabilities by integrating them into a secure, decentralized network. The project’s first set of agents focus is on improving DeFi experiences via advanced AI agents like ELANN.AI. Upcoming steps include a mainnet launch and the release of a technical whitepaper on May 15.

Jaideep Kewalramani, COO and Head of Employability Business of TeamLease Edtech, says the rapid growth makes it difficult to precisely quantify the change in open positions over the past three years, especially as the segment is dynamic and evolving. “As a sunrise industry, the demand for semiconductor professionals has surged significantly. While specific data may vary across companies and sub-sectors, a conservative estimate suggests a compound annual growth rate (CAGR) of around 100% in open positions over the last three years,” he says. But experts point out that there is no doubt about the rising demand for talent in this segment.

Stock market today: Despite weakness across segments on Dalal Street, Indegene share price listed on BSE and NSE at a bumper premium. Indegene share price is listed on BSE at ₹659.70 per share, whereas on NSE, Indegene shares are listed at ₹655 apiece.

IIFL Securities Limited, a leading financial services house, today said that it has appointed Mr. Nemkumar H, Whole-Time Director on the Board, as the Managing Director with effect from May 15, 2024 for a period of 5 years. Mr.

39.5% of men and women will be diagnosed with cancer at some point during their lifetimes. Witnessing a loved one endure the debilitating side effects that most often accompany cancer treatments is an experience no one should have to go through, especially as a patient. Yet, it seems advances in cancer treatment have been slow-moving, toxic, and extremely expensive.

Stock market crash: After logging a bounce back on Friday last week, the Indian stock market again came under the selling pressure as frontline indices lost up to one percent in early morning session. The Nifty 50 index opened lower at the 22,027 mark and touched the intraday low of 21,821, whereas the BSE Sensex opened lower and touched an intraday low of 71,866. The Bank Nifty index also had a gap down, opening at 47,389, and the index touched an intraday low of 46,983.

Buy or sell stocks for today: The performance of the Nifty 50 index is a key indicator of the Indian stock market's health. Despite the index ending higher on Friday's session, the market experienced its worst week in nearly two months. This was due to nervous election-related unloading, which continued at a slower pace.

Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier U.S. rate cuts, while Chinese activity data will test optimism about a sustained recovery in the world's No. 2 economy. Beijing has already reported a welcome pickup in inflation to an annual 0.3% in April, helping to soothe worries about a slide into prolonged deflation. Forecasts favour further gains in April retail sales and industrial output due on Friday.

Srinivas Pallia replaced Thierry Delaporte in the corner room of Bengaluru-headquartered Wipro Ltd, the company is attempting to settle lawsuits it had filed against two former senior executives, according to a review of court filings and two executives aware of the development. Jatin Dalal, former chief financial officer of Wipro, and Mohd Ehteshamul Haque, the company’s former senior vice president and head of healthcare and medical devices business, were sued by India’s fourth-largest IT services company for breach of employment contracts. Both had joined rival Cognizant Technology Solutions Corp less than 12 months after resigning from Wipro.

Mint had reported that Accenture, which earns twice as much as TCS in annual revenues, had taken a swipe at TCS’s digital offerings under Business 4.0, via its digital solutions platform, Accenture X.O. “Stop playing catch-up and start applying digital at the core of your business to reinvent for a new era of industry. Go beyond Industry 4.0: If you think Industry 4.0 is the epitome of industrial digitization—think again.

outflow of ₹396 crore last month, making it the first withdrawal after March 2023, owing to profit booking. Despite the decline, the asset under management (AUM) of gold funds rose 5% to ₹32,789 crore at April-end from ₹31,224 crore in the preceding month, according to the data with the Association of Mutual Funds in India (Amfi).

drug regulator has formed an expert panel to evaluate several currently prescription drugs that can be sold over the counter (OTC) after various pharmaceutical companies lobbied the regulator to make their drugs an OTC product, people in the know told ET. The sub-committee, which includes various doctors from the country's top government hospitals, representatives from Indian Council of Medical Research (ICMR), drug controllers from various states, will develop a mechanism for the drugs to be sold OTC, considering globally prevalent regulations and practices. The sub-committee formed last week has been asked to submit the report within three months.

Demand for daily groceries, essentials and household products will likely be muted in the current quarter, global research firm Kantar said, but it indicated a rural-led recovery in the second half of FY25 even though urban consumption could remain a relative straggler. Overall volumes, which indicate the number of products consumers bought, expanded 5.2% in the March quarter, unchanged from the three months to December. Sales volumes in rural markets climbed 5.8%, and in cities by 4.7%, from a year earlier, data from Kantar showed. Kantar monitors branded and unorganised products, including unpackaged voluminous commodities. Nielsen, on the other hand, tracks primarily branded retail sales. «There was significant inflation that led to shrinkflation, or consumers downgrading. But the worst is behind us and there is visibility of better growth,» said Saugata Gupta, managing director, Marico. «There will obviously be volume improvement although there will be some pricing growth as well. We definitely see a double-digit revenue growth.»

high growth though geopolitical uncertainties and tepid consumption remain a concern, say economists. CII's business confidence index touched a 12-quarter high in Q4FY24, with 51% of firms expecting capacity utilisation of 75% and above. Moreover, 71% expect an improvement in private capex in the first half of FY25 compared with the second half of FY24. Private investment proposals sanctioned by banks rose by nearly Rs 1 lakh crore to Rs 3 lakh crore in the last year alone, according to India Ratings and Research (Ind-Ra).